Bär & Karrer advises Joint Bookrunners on Placement of CHF 200 Million 2.75% Convertible Bonds by Basilea Pharmaceutica AG

Basilea has successfully placed CHF 200 Million 2.75% convertible bonds due 2022. The bonds provide a share settlement option and were issued at 100% of their principal amount. The convertible bonds will mature on 23 December 2022 at 100% of their principal amount unless previously redeemed, converted or repurchased and cancelled. J.P. Morgan Securities plc and UBS AG acted as Joint Bookrunners in this transaction.

Bär & Karrer acted as legal advisor to the Joint Bookrunners. The team included Thomas U. Reutter, Roland Truffer, Daniel Heiniger, Annette Weber and Anouk Hirt (all Capital Markets) as well as Susanne Schreiber and Andreas Steffen (both Tax).